news
The European Life Sciences Community meets at BASEL LIFE
Leading experts of the European Life Sciences Community are engaging under the name BASEL LIFE to establish a bridge between science and business.
List view / Grid view
Drug Development
news
Animal model of Huntington’s offers advantages for testing treatments
Using genetic engineering technology, a team of scientists have established an animal model of Huntington's disease...
news
I-BET-762 may stop cancer-causing gene in its tracks
Scientists are testing a promising drug that may stop a gene associated with obesity from triggering breast and lung cancer...
news
Medicinal cannabis is safe and effective — it’s time to reboot research
Researchers claim that medicinal cannabis is safe and effective for pain relief, and are calling for the treatment to be properly established in our modern medical arsenal...
news
Researchers identify compound to prevent breast cancer cells from activating in brain
Researchers have used computer modelling to find an existing investigational drug compound for leukaemia patients to treat triple negative breast cancer...
news
Experimental obesity drug prevents development of kidney stones
Scientists have found that a drug connected with fat regulation prevents the formation of kidney stones in mice...
news
New treatment for aggressive breast cancer
Researchers have uncovered a way to treat aggressive tumours through manipulation of the connective tissue cells of the tumour.
news
Combination therapy suppresses HIV-like virus in primates
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
news
Scientists advocate less toxic treatment for rare leukaemia (MPAL)
Researchers in the US have undertaken meta-analysis studies to ascertain the optimum approach for doctors treating rare mixed phenotype acute leukaemia (MPAL). They found that a less-toxic regimen gives better results.
news
Tempol provides a potential treatment for Chuvash polycythemia
A study in mice suggests that experimental drug may be effective against mountain sickness and other polycythemias...
news
Antibodies provide potential targets for RSV vaccine development
Scientists have found and characterised the activity of four antibodies produced by the human immune system that targets an important protein found in the respiratory syncytial virus...
news
Organ-on-chip technology tests for hepatitis B virus
Scientists have become the first in the world to test how pathogens interact with artificial human organs...
news
BX795 molecule clears HSV-1 infection in human corneal cells
Researchers at the have identified a small drug molecule that can clear the herpes simplex virus-1 infection, making it a promising potential option for patients who have developed resistance...
news
Mirror-image peptides of existing drugs provide longer-lasting therapeutic effects
Researchers have developed a new technology for creating more durable disease-fighting molecules which could lead to drugs with longer-lasting effects...
